Immediate Impact

1 by Nobel laureates 1 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)
2022 Standout
1 intermediate paper

Works of Mari Asada being referenced

Suppression of the hypothalamic–pituitary–gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: Studies in human GnRH receptor knock-in mice
2013
Effect of glycogen synthase kinase 3 β-mediated presenilin 1 phosphorylation on amyloid β production is negatively regulated by insulin receptor cleavage
2011

Author Peers

Author Last Decade Papers Cites
Mari Asada 100 112 1 43 17 232
Francesco Capodanno 70 152 41 20 286
Libo Sun 84 83 4 24 21 286
Mbarka Dakouane‐Giudicelli 116 88 55 16 281
Courtney L. Andersen 138 76 65 17 272
R Wyss 91 69 3 80 12 269
Helen H. Kim 93 156 69 15 297
Wenbai Zhou 156 28 1 49 17 293
Xiaoyue Shen 117 94 10 21 30 295
Anthony H. Taylor 61 39 22 15 197
Anna C Nackley 72 128 3 54 20 298

All Works

Loading papers...

Rankless by CCL
2026